Network analysis to explore the pharmacological mechanism of Shenmai injection in treating granulocytopenia and evidence-based medicine approach validation

Shenmai injection is frequently utilized in China to clinically treat granulocytopenia in oncology patients following chemotherapy. Despite this, the drug’s therapeutic benefits remain a topic of contention, and its active components and potential treatment targets have yet to be established. The pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Xianbing, Chen, Dandan, Wang, Yao, Cui, Bixian, Xu, Hui, Wang, Yuanyuan, Chen, Hongzhou, Wang, Dan, Chen, Ying, Cheng, Tongfei, Dai, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194581/
https://www.ncbi.nlm.nih.gov/pubmed/37335746
http://dx.doi.org/10.1097/MD.0000000000033825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194581/
https://www.ncbi.nlm.nih.gov/pubmed/37335746
http://dx.doi.org/10.1097/MD.0000000000033825

Ejemplares similares